当前位置:首页 > 股票大全 > 昭衍新药 603127 财务分析

昭衍新药财务分析

整理编辑：168股票行情网：www.gphq168.com    数据来源：互联网 经供参考

昭衍新药(603127)利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入324,809,103.672,376,486,797.11,587,079,779.381,012,077,288.18
营业总成本293,294,646.961,622,010,226.391,104,837,171.01714,196,615.6
营业利润-293,008,274.73507,096,321.21392,084,940116,839,105.61
利润总额-293,130,015.64506,950,437.23391,985,180.41116,935,671.75
净利润-273,363,603.07391,552,561.64326,197,002.6589,508,170.24
其他综合收益863,793.544,960,762.6710,184,198.0213,252,126.55
综合收益总额-272,499,809.53396,513,324.31336,381,200.67102,760,296.79
昭衍新药(603127)资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计6,971,164,178.587,121,967,340.117,248,202,099.955,781,980,364.11
非流动资产合计2,762,090,308.722,905,192,290.362,984,467,964.584,437,329,670.94
资产总计9,733,254,487.310,027,159,630.4710,232,670,064.5310,219,310,035.05
流动负债合计1,502,563,540.441,467,365,088.641,690,352,621.161,900,397,225.76
非流动负债合计236,962,783.63278,754,126.75302,170,027.52294,852,420.91
负债合计1,739,526,324.071,746,119,215.391,992,522,648.682,195,249,646.67
归属于母公司股东权益合计7,993,144,600.588,279,315,724.358,234,384,077.378,018,014,677.35
股东权益合计7,993,728,163.238,281,040,415.088,240,147,415.858,024,060,388.38
负债和股东权益合计9,733,254,487.310,027,159,630.4710,232,670,064.5310,219,310,035.05
昭衍新药(603127)现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计492,589,961.12,433,306,501.421,874,131,001.011,261,717,481.39
经营活动现金流出小计372,636,441.791,810,431,362.981,425,690,782.591,015,507,733.02
经营活动产生的现金流量净额119,953,519.31622,875,138.44448,440,218.42246,209,748.37
投资活动现金流入小计111,453,520.72623,903,128.48528,639,464.14326,802,768.55
投资活动现金流出小计179,015,819.37939,332,589.88665,787,220.01369,109,478.54
投资活动产生的现金流量净额-67,562,298.65-315,429,461.4-137,147,755.87-42,306,709.99
筹资活动现金流入小计----
筹资活动现金流出小计37,928,364.49361,677,897.08333,289,197.7593,602,620.47
筹资活动产生的现金流量净额-37,928,364.49-361,677,897.08-333,289,197.75-93,602,620.47
汇率变动对现金及现金等价物的影响-2,795,727.798,409,667.4813,801,951.617,779,109.73
现金及现金等价物净增加额11,667,128.38-45,822,552.56-8,194,783.6128,079,527.64
期末现金及现金等价物余额2,865,314,156.352,853,647,027.972,891,274,796.933,027,549,108.17
昭衍新药603127相关数据
今日股市大盘指数